Perfil
Bruno Besse is currently the Chief Medical Officer at Quantum Genomics SA. He previously worked as a Principal at Roche Diagnostics GmbH, Head-Medical Affairs at Crossject SA, and Principal at Aventis Pharma SARL. Dr. Besse completed his undergraduate degree at INSEAD and holds a doctorate from Université de Paris XI Paris Sud.
Cargos activos de Bruno Besse
| Empresas | Cargo | Inicio |
|---|---|---|
| QUANTUM GENOMICS | Director Técnico/Científico/I+D | 01/03/2017 |
Antiguos cargos conocidos de Bruno Besse.
| Empresas | Cargo | Fin |
|---|---|---|
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Corporate Officer/Principal | - |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
| CROSSJECT | Director Técnico/Científico/I+D | - |
Formación de Bruno Besse.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Commercial Services |
Crossject SA
Crossject SA Medical SpecialtiesHealth Technology Designs and develops needle free, pre-filled single-use injection systems | Health Technology |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris XI Paris Sud
Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quantum Genomics SA
Quantum Genomics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cardiovascular diseases | Health Technology |
- Bolsa de valores
- Insiders
- Bruno Besse
















